Dublin, April 21, 2025 (GLOBE NEWSWIRE) -- The "Biosensors - A Global Market Overview" has been added to ResearchAndMarkets.com's offering.
The biosensors market is projected to surge from US$30.6 billion in 2024 to US$49.6 billion by 2030, reflecting a CAGR of 8.4% between 2024 and 2030. Biosensors, regarded as technological marvels, have significantly enhanced diagnostics and patient monitoring, particularly in personalized medicine and healthcare delivery. Key advancements driving this growth include the proliferation of wearable technology such as smartwatches and fitness trackers, which provide continuous health monitoring and real-time data.
Technology and Trends
Recent innovations in biosensors, notably through nanotechnology with nanoparticles and nanowires, have resulted in miniaturized and highly sensitive devices for superior detection capabilities. Multiplexed biosensors, capable of detecting multiple analytes in a single sample, are becoming invaluable for comprehensive diagnostics in areas such as cancer and infectious disease monitoring. Additionally, AI and big data analytics are increasingly integrated into biosensors, enhancing diagnostic accuracy and facilitating predictive healthcare.
Regional Market Insights
North America leads the global market due to a high incidence of chronic diseases and robust technological advancements, supported by a well-developed healthcare system and substantial government investments. Asia-Pacific is expected to exhibit the fastest growth, driven by a large aging population, increasing disposable income, and improved healthcare infrastructure in countries like China and India. Furthermore, R&D efforts and the application of biosensors in environmental monitoring and food toxicity assessments are gaining momentum.
Market Segmentation
Electrochemical biosensors dominate the market, accounting for over 70% of the share in 2024, buoyed by their application in glucose monitoring devices and point-of-care settings. Optical biosensors are anticipated to grow rapidly, renowned for their ultrasensitive properties suitable for early disease detection.
Product and Application Analysis
Wearable biosensors outrank non-wearables in demand and growth, celebrated for their real-time health monitoring capabilities and seamless integration with smartphone and smartwatch technologies. In medical testing, the demand for biosensors is highest for blood glucose testing, followed by cholesterol and pregnancy tests. The agricultural sector is set to witness the fastest growth in biosensor adoption, aiding in the detection of fungi, heavy metals, and pesticides, and facilitating soil disease predictions.
End-User Perspective
Point-of-Care (PoC) testing is the largest end-user segment, leveraging biosensors for precise and rapid test results across diverse medical settings. PoC's broad scope encompasses a range of tests that enhance healthcare interventions, a trend poised to accelerate with ongoing technological advances in biosensors.
Report Scope and Coverage
The report provides a comprehensive analysis of global and regional biosensor markets from 2021 to 2030, with detailed forecasts and company profiles illustrating the industry's progress and innovation landscape.
Key Metrics
- Historical Period: 2021-2023
- Base Year: 2024
- Forecast Period: 2024-2030
- Units: Market value in US$
Geographic Breakdown
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Technology Segments
- Electrochemical
- Optical
- Piezoelectric
- Thermal
Product Types and Applications
- Non-Wearable
- Wearable
- Agriculture Testing
- Environment Testing
- Food & Beverage Testing
- Medical Testing
End-User Segments
- Home-Based Testing
- Point-of-Care Testing
- Research Laboratories
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 408 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $30.6 Billion |
| Forecasted Market Value (USD) by 2030 | $49.6 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
Companies Featured
- Abbott Laboratories
- ACON Laboratories, Inc.
- AerBetic
- AgaMatrix, Inc.
- Agilent Technologies, Inc.
- Analog Devices, Inc.
- Ascensia Diabetes Care Holdings AG
- AZUR Environmental
- Bayer AG
- bioM?rieux SA
- Bio-Rad Laboratories, Inc.
- Biosensor BV
- Biosensors International Group Ltd.
- Broadcom
- Bruker Corp
- Cranfield Biotecnology Centre
- Cytiva
- Danaher Corporation
- Dexcom, Inc.
- DuPont Biosensor Materials
- Dynamic Biosensors GmbH
- EG & IC Sensors, Inc.
- Ercon, Inc.
- F. Hoffmann-La Roche AG
- GlySens Incorporated
- Huawei Technologies
- Infineon Technologies AG
- Innovative Biosensors, Inc.
- i-SENS, Inc.
- Johnson & Johnson
- Koninklijke Philips N.V.
- LamdaGen Corp
- LifeScan, Inc.
- LifeSensors, Inc.
- Masimo Corp
- Medtronic Plc
- Molecular Devices Corp
- Molex LLC
- Nanowear, Inc.
- Nix Biosesnors, Inc.
- Nova Biomedical
- Panasonic Corp
- PerkinElmer, Inc.
- Pharmaco-Kinesis Corp
- Pinnacle Technologies, Inc.
- Polestar Technologies, Inc.
- QTL Biodetection LLC
- Robert Bosch GmbH
- Roche Diagnostics
- SD Biosensor, Inc.
- Siemens Healthineers AG
- Strategic Diagnostics
- Sysmex Corporation
- TaiDoc Technology Corp
- TDK Corp
- TE Connectivity Corporation
- Texas Instruments, Inc.
- Thermo Fisher Scientific, Inc.
- Trividia Health, Inc.
- Universal Biosensors, Inc.
- VitalConnect
- Withings SA
- World Precision Instruments, Inc.
- Zimmer & Peacock AS
For more information about this report visit https://www.researchandmarkets.com/r/4vgrqk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
